HOME >> MEDICINE >> NEWS
New data provide further evidence of effectiveness of targeted delivery of Relenza and efficacy in both A&B strains

San Francisco, 28 September, 1999: The targeted delivery of Relenza results in high concentrations of the drug in the primary site of viral replication, the lungs, up to 24 hours after inhalation. It is also effective against A& B strain influenza, and reduces complications requiring antibiotics. These are the conclusions from three studies of Relenza (zanamivir), the new anti-flu treatment, being presented to physicians at a major anti-viral conference.

The data presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 26-29, in San Francisco, USA, provide further evidence of the effectiveness of Relenza, and its highly targeted mode of administration, against both A & B strains of influenza.

Results from a laboratory study, presented at ICAAC1, showed that the inhalation of Relenza resulted in a high concentration of the drug in the lungs. These levels of the drug allow for continued anti-viral activity at the major site of viral replication and were retained up to 24 hours after a single 10mg inhaled dose. These data strongly support the use of an inhaled therapy that delivers its effect direct to the site of major viral replication.

A further benefit of the high concentrations achieved in the respiratory tract is that the possibility of development of resistance to the drug is reduced. Other influenza anti-virals have been of limited clinical use because the virus can often develop resistance to them rapidly.

The efficacy of the drug against influenza B was demonstrated by a meta-analysis of 220 patients, with confirmed B strain flu, from a total of 1,572 patients involved in five placebo-controlled studies. Using a regimen of 10mg twice daily (bid) for five days2, time to alleviation of symptoms (the primary endpoint) was reduced by 25 per cent to 4.5 days for those taking Relenza, down from 6.0 days for those on placebo.

The results of this analysis confirm the efficacy of Relenza in
'"/>

Contact: Jeremy Payne
jyp96669@glaxowellcome.co.uk
44-181-966-4719
CPR Worldwide
28-Sep-1999


Page: 1 2

Related medicine news :

1. Study provides new estimates of the causes of child mortality worldwide
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. End AIDS drug waiting lists, HIV care providers tell policymakers
4. Artery clearing system does not provide benefit for patients undergoing PCI
5. Newly identified gene cluster on mouse X chromosome provides insights into fertility
6. University of Washington joins new Autism Treatment Network to provide better medical services
7. Rat whisking may provide insight into debilitating eye disorder
8. Researchers hope monkeys can provide new insights into depression
9. AGI and USGS provide unique tsunami disaster relief
10. New ITN Scholars Program provides junior faculty opportunity to develop clinical trials expertise
11. Pegaptanib provides benefit for neovascular age-related macular degeneration

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and fastest ... to open a flagship location in Covington, LA at 401 N. U.S. Highway 190, ... next to Office Depot in the Holiday Square shopping center. Its location allows it ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will ... the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey ... Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... $3,296 in property taxes a year. In some states—like New York, New Jersey, ... By contrast, many overseas retirement havens have extremely low property-tax rates, which contributes ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
(Date:10/4/2017)... Oct. 4, 2017  According to the Centers for Disease Control and ... October . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the ... certain health insurance regulations. ... time to get a flu shot is by the end of October, ...
Breaking Medicine Technology:
Cached News: